Introduction {#cesec10}
============

Knee replacement is one of the most common elective surgical procedures worldwide. The National Joint Registry for England, Wales, Northern Ireland and the Isle of Man recorded 102 777 knee replacements performed in 2017, and the secular trend continues to increase.[@bib1] Deep infection is a rare but devastating complication affecting approximately 4% of primary and 15% of revision knee replacements.[@bib2] The most common causative organisms remain coagulase-negative staphylococci and *Staphylococcus aureus*, which are usually sensitive to a range of antibiotics.[@bib3] Treatment of prosthetic joint infection is expensive and protracted, and both the infection and the treatment have profoundly negative effects on patients and their families.[@bib4], [@bib5], [@bib6], [@bib7] Treatment options include antibiotic suppression, debridement and retention of implants, excisional arthroplasty, and one-stage or two-stage revision.[@bib8], [@bib9] However, all of these treatment options are associated with substantial morbidity and a high risk of adverse outcomes. As knee replacements have become more common, the number of revision operations for infection between 2005 and 2013 in England and Wales has risen by more than threefold, with more than 1000 revision procedures due to prosthetic joint infection of the knee done annually since 2011.[@bib10]

Research in context**Evidence before this study**Prosthetic joint infection, although a rare complication following total joint replacement, is associated with devastating consequences. Evidence suggests that the risk of developing prosthetic joint infection following total hip or knee replacement is likely to be affected by patient-related, surgery-related, and health-care system-related factors. However, since total hip and knee replacements are two different operations involving patients with differing risk profiles, whether these factors affect prosthetic joint infection rates differentially in these patient groups remains uncertain. In a meta-analysis of 66 studies comprising more than 500 000 total joint replacements and published by our group in 2016, patient-related factors such as male sex, high body-mass index (BMI), steroid use, diabetes, rheumatoid arthritis, congestive heart failure, depression, and smoking and alcohol intake were each found to be associated with an increased risk of prosthetic joint infection. In a single cohort prospective study published in September, 2018, and comprising more than 600 000 primary hip replacements, we confirmed previous findings and showed several additional patient factors (eg, younger age, chronic pulmonary disease, and liver disease) and surgical factors (eg, surgery type, lateral surgical approach, and non-ceramic bearing surfaces) to be associated with an increased risk of infection. We also demonstrated that these factors exhibit specific time effects following surgery. However, the evidence for total knee replacements is less robust. We searched MEDLINE, Embase, and Web of Science from the date of the last search of the 2016 review (Sept 1, 2015) up to August, 2018, for observational cohort studies and systematic reviews and meta-analyses reporting on associations of patient-related, surgery-related, or health-care system-related factors with risk of prosthetic joint infection following total knee replacement. We used search terms related to the exposures (eg, "risk factor", "body mass index", and "comorbidity") with those related to prosthetic joint infection (eg, "peri-prosthetic joint infection" and "prosthetic joint infection"). Our search was not restricted by language. We identified several registry studies and a meta-analysis based on 16 studies, whose findings are consistent with previous work on the topic. Existing evidence for the role of patient-related, surgery-related, or health-care system-related factors on prosthetic joint infection risk following total knee replacement is limited by inadequate sample sizes, short follow-up durations, inadequate adjustment for confounders, substantial inter-study heterogeneity, and inability to account for time-specific effects during follow-up.**Added value of this study**Using a single observational cohort of 679 010 primary total knee replacements, this study evaluated the overall and time-specific associations of patient, surgical, and health-care system factors on the risk of revision for prosthetic joint infection. Over a median follow-up of 4·6 years, 3659 knees were revised for prosthetic joint infection. Patient factors such as male sex, younger age (\<60 years), high BMI (≥25 kg/m^2^), chronic pulmonary disease, diabetes, liver disease, connective tissue or rheumatic disease, and peripheral vascular disease were each associated with an increased risk of revision for prosthetic joint infection. Surgical factors such as indications for the primary procedure, type of procedure, and implant fixation and constraint or bearing significantly affected the risk of revision for prosthetic joint infection. Patients who received general anaesthesia or a tibial bone graft had an increased risk of revision, whereas the risk was lower for those who received a spinal anaesthetic. On the role of health-care system characteristics, high-volume hospitals had an increased risk of revision for prosthetic joint infection and privately funded procedures carried a lower risk of revision than operations funded by the NHS. Factors such as male sex and younger age had a consistent effect during the entire postoperative period, whereas other factors (such as indications for the primary procedure, type of procedure, and implant fixation and constraint or bearing) exhibited time-specific effects on revision for prosthetic joint infection.**Implications of all the available evidence**With the ageing population and a projected increase in total knee replacements, the burden of prosthetic joint infection will rise proportionately. The development of a prosthetic joint infection following total knee replacement is influenced by several modifiable and non-modifiable factors, which also seem to exhibit time-specific effects. Awareness of these factors and their time-specific effects should assist clinicians in appropriate counselling of patients preoperatively, optimisation of patients before surgery, as well as enhanced monitoring of at-risk patients after surgery.

The risk of developing infection after any form of arthroplasty is affected by both modifiable and non-modifiable patient, surgical, and health-care system factors. A recent systematic review of patient risk factors for prosthetic joint infection in both hip and knee replacements identified male sex, smoking, increasing body-mass index (BMI), steroid use, previous joint surgery, and comorbidities such as diabetes, rheumatoid arthritis, and depression, as notable risk factors for infection.[@bib11] However, limitations of this study and other reviews include short follow-up, pooled estimates based on variably adjusted data, and evidence of substantial heterogeneity between studies.[@bib11], [@bib12]

In view of these limitations, there is a need for large-scale cohort studies with adequate power to provide evidence about the nature and magnitude of the associations of potential risk factors with prosthetic joint infection. We recently published one such study about infection following hip replacement, which highlighted the importance of disentangling the time-specific effects of factors associated with early onset of prosthetic joint infection that are likely to be the consequence of the primary intervention versus factors associated with later onset that are more likely to result from haematogenous spread.[@bib9], [@bib13]

Although they are often studied together, hip and knee osteoarthritis are in some regards very different diseases[@bib14] with varying responses to joint replacement.[@bib15] Orthopaedic surgeons often specialise in either hip or knee replacement, and surgical techniques and implants aim to address specific issues relating to joint structure and function. Furthermore, patient recovery,[@bib16] outcomes,[@bib17] and rates of complications including prosthetic joint infection[@bib10], [@bib18] differ between hip and knee replacement.

In this study, we aimed to assess the overall and post-operative period-specific associations of patient, surgical, and health-care setting factors with the risk of revision due to prosthetic joint infection in prospectively collected observational data of primary knee replacements done in England and Wales. We also aimed to investigate whether these factors differed from those associated with revision for prosthetic joint infection after hip replacement.

Methods {#cesec20}
=======

Study design and data sources {#cesec30}
-----------------------------

In this observational cohort study, we report analyses of data for England and Wales from the National Joint Registry for England, Wales, Northern Ireland, and the Isle of Man between April 1, 2003, and December 31, 2014. Data collection for Northern Ireland and the Isle of Man could not be considered due to their low number of procedures and insufficient duration of follow-up.

National Joint Registry data were linked to Hospital Episode Statistics in England and the Patient Episode Database for Wales to obtain data about inpatient and day case admissions. Data from the Office for National Statistics were linked to obtain the date of death.

Patient consent was obtained for data collection and linkage by the National Joint Registry. According to the NHS Health Research Authority, separate consent and ethics approval were not required for this study.

Procedures {#cesec40}
----------

We analysed primary knee replacements done between April 1, 2003, and Dec 31, 2013, and revision procedures for prosthetic joint infection that occurred after the primary replacement between April 1, 2003, and Dec 31, 2014. The reason for revision is recorded by clinicians at the time of the revision procedure and reflects a clinical judgement sufficient to lead the surgeon to do an invasive procedure tailored to treat prosthetic joint infection. The diagnosis and treatment strategy for prosthetic joint infection is at the discretion of the surgeon and treating unit and is reflective of contemporary practice during the study period, with raised inflammatory markers, joint-specific symptoms, sinuses, and positive microbiological cultures[@bib19] being common diagnostic features during that period.

Each primary replacement was followed for a minimum of 12 months until the end of the observation period (Dec 31, 2014) or until the date of revision for prosthetic joint infection, revision for another indication, or death (whichever occurred first). Revisions for prosthetic joint infection included debridement and implant retention with modular exchange, or a single-stage or two-stage revision procedure.[@bib20]

Patient characteristics[@bib21] considered were age, sex, ethnicity, BMI, American Society of Anesthesiologists (ASA) grade, and comorbidities. Ethnicity and comorbidities were obtained from the Hospital Episode Statistics records. We used International Classification of Diseases, 10th revision codes to classify comorbidities for which patients had been admitted to hospital in the 5 years preceding their primary operation ([appendix p 2](#sec1){ref-type="sec"}).[@bib22]

Surgical factors[@bib21] considered were indication for surgery, anaesthesia type, thromboprophylaxis regime, surgical approach, knee replacement type, fixation, degree of constraint, use of bone graft, and occurrence of intraoperative complications ([appendix p 2](#sec1){ref-type="sec"}).

Health-care system factors[@bib21] considered were hospital type, funding source (National Health Service \[NHS\] or private), country, operating surgeon grade, consultant involvement, and the volume of knee surgeries (categorised into quartiles) done by the operating surgeon and surgeon in charge of the procedure in the preceding 12 months.

Statistical analysis {#cesec50}
--------------------

The associations between the risk factors and risk of revision for prosthetic joint infection were first investigated during the overall follow-up period. Poisson multilevel models accounting for clustering at the unit level (random intercept) were used. Clustering at the surgeon level was negligible and therefore not considered further.

Prosthetic joint infection management can vary according to the time elapsed since the primary procedure at the time of onset of infection. Early onset of infection (within 2 years of the primary procedure) is generally believed to result from the primary intervention. Later onset of infection (2 years or longer after the primary procedure) is more likely to be due to haematogenous spread.[@bib9] For patients with early postoperative or acute haematogenous infection and a short duration of symptoms, debridement, modular exchange, and implant retention rather than full revision is appropriate if the joint replacement is well fixed.[@bib9] The associations between risk factors and risk of revision were therefore re-investigated over several at-risk post-operative periods: 0--3 months, 3--6 months, 6--12 months, 12--24 months, and more than 24 months. Each participant\'s at-risk period (defined as the time elapsed between their primary procedure and the endpoint) was split according to the time spent in each of these periods and the revision for prosthetic joint infection status (revised for prosthetic joint infection *vs* not) was assigned to the relevant period. We used a piecewise exponential multilevel model with period-specific effects to assess these associations---ie, their rate ratios (RRs) and 95% CIs across these time periods.[@bib23], [@bib24] Analyses were done by running MLwiN from Stata version 14.1 using Markov Chain Monte Carlo methods.[@bib25] To account for test multiplicity, adjusted p values were derived using Simes\' false-discovery rate testing controlling procedure.[@bib26], [@bib27] To be confident that 95% of the effects tested were not due to chance, evidence of association was only discussed for adjusted p values of up to 0·05.

The analyses were done on the overall sample for all exposures except for ethnicity and comorbidities, which were only investigated in the patients operated on in England with record of hospital admission in Hospital Episode Statistics, but not in the Patient Episode Database for Wales and no evidence of residency outside England. The regressions were adjusted for age, sex, ASA grade, and BMI. BMI is an important risk factor for prosthetic joint infection but has substantial missing data in the National Joint Registry (47%), partly because it was not included as a variable in the early data collection forms. A missing at random mechanism was assumed to account for observed factors associated with the propensity of BMI to be missing and avoid the use of a complete-case analysis, which would have produced biased estimates: mean time at risk in missing BMI group 5·9 years (SD 2·8) versus 4·1 years (2·3) in the complete BMI group; incidence of revision for prosthetic joint infection 0·58 (95% CI 0·55--0·62) versus 1·68 (1·62--1·75); uncemented total knee replacement 6·0% versus 4·1%; other type of total knee replacement 1·6% versus 0·8%, unicondylar procedure 7·9% versus 9·3%. This approach also allowed us to use the entire study sample and investigate the rare exposure, something precluded with a complete case approach. A multiple imputation strategy was used to impute BMI using a Gaussian normal regression imputation model with the above factors used as covariates as well as the log of the observed event or censoring time, knee replacement type, and revision for prosthetic joint infection status. Because of the computational time required by each multilevel piecewise model, five imputations were computed and no sensitivity analyses of our missing at random approach were done. Estimates were combined by Rubin\'s rules. Unadjusted and adjusted models without BMI are available on request. To avoid over-adjustment, models investigating the effect of comorbidities were not adjusted for ASA grade, a proxy indicator of comorbidity profile.

Role of the funding source {#cesec60}
--------------------------

The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. EL had full access to all the data in the study. AWB is the guarantor and had final responsibility for the decision to submit for publication.

Results {#cesec70}
=======

Baseline study sample characteristics are presented in [figure 1](#fig1){ref-type="fig"} and the [table](#tbl1){ref-type="table"}. 679 010 primary knee procedures were done in 449 different surgical units with a median of 1142 procedures (IQR 564--2144) per unit. Baseline characteristics were assessed in all 679 010 primary knee procedures, except for ethnicity and comorbidities, which were only investigated in the 557 426 patients operated on in England with record of hospital admission in Hospital Episode Statistics, but not in the Patient Episode Database for Wales and no evidence of residency outside England ([figure 1](#fig1){ref-type="fig"}, [appendix p 2](#sec1){ref-type="sec"}). 3659 index procedures were subsequently revised for an indication of prosthetic joint infection after a median follow-up of 4·6 years (IQR 2·6--6·9): 245 (6·7%) of these within 3 months, 238 (6·5%) between 3 and 6 months, 628 (17·2%) between 6 and 12 months, 970 (26·5%) between 1 and 2 years, and 1578 (43·1%) beyond 2 years from the index procedure. The median patient age was 70 years (IQR 63--76). The sample is presented by time periods in [appendix pp 4--9](#sec1){ref-type="sec"}. In 792 (28%) of the 2833 two-stage revision procedures done for prosthetic joint infection, only a second stage procedure was recorded in the National Joint Registry. Patients with incompletely registered two-stage procedures did not differ from those with complete procedures and their time to first stage procedure was estimated ([appendix p 1](#sec1){ref-type="sec"}).Figure 1Study sampleHES=Hospital Episode Statistics for England. PEDW=Patient Episode Database for Wales. \*In this research, only data for England and Wales were considered; data collection for Northern Ireland commenced on Feb 1, 2013, and primary and revision procedures from this country could not be considered because of their low number and short follow-up. Data collection for the Isle of Man commenced on July 1, 2015, which was after the endpoint of the study and therefore these data were not considered. †As recorded in HES for the 5 years preceding the primary knee replacement.TableSample description and incidence rates**nPerson-years of follow-upCasesIncidence rate per 1000 person-years (95% CI)Patient characteristics**SexFemale386 0471 913 85815640·82 (0·78--0·86)Male292 9631 418 43720951·48 (1·41--1·54)Age, years\<60109 000537 0807931·48 (1·38--1·58)60--69229 1071 143 67013421·17 (1·11--1·24)70--79247 6361 233 47812230·99 (0·94--1·05)≥8093 267418 0663010·72 (0·64--0·81)Ethnic originWhite515 0982 491 24530661·23 (1·19--1·28)Black African origin601127 217521·91 (1·43--2·51)South Asian15 51069 500941·35 (1·09--1·66)Other and mixed651328 414401·41 (1·01--1·92)Unclear14 29471 896300·42 (0·28--0·60)Unavailable[\*](#tbl1fn1){ref-type="table-fn"}121 584644 0233770·59 (0·53--0·65)BMI, kg/m^2^\<2540 333167 4162121·27 (1·10--1·45)25--29·9131 560548 5058491·55 (1·45--1·66)≥30205 134840 04115581·85 (1·76--1·95)Missing301 9831 776 33310400·59 (0·55--0·62)ASA grade192 441523 0234900·94 (0·86--1·02)2484 9922 347 55924601·05 (1·01--1·09)3--5101 577461 7137091·54 (1·42--1·65)Chronic pulmonary diseaseNo478 7882 350 41628221·20 (1·16--1·25)Yes78 638337 8564601·36 (1·24--1·49)Unavailable[\*](#tbl1fn1){ref-type="table-fn"}121 584644 0233770·59 (0·53--0·65)DiabetesNo490 5212 398 43928091·17 (1·13--1·22)Yes66 905289 8334731·63 (1·49--1·79)Unavailable[\*](#tbl1fn1){ref-type="table-fn"}121 584644 0233770·59 (0·53--0·65)DementiaNo555 7832 682 65132741·22 (1·18--1·26)Yes1643562181·42 (0·61--2·80)Unavailable[\*](#tbl1fn1){ref-type="table-fn"}121 584644 0233770·59 (0·53--0·65)Liver diseaseNo553 3892 672 86632371·21 (1·17--1·25)Yes403715 406452·92 (2·13--3·91)Unavailable[\*](#tbl1fn1){ref-type="table-fn"}121 584644 0233770·59 (0·53--0·65)Congestive heart failureNo546 6132 643 87232111·21 (1·17--1·26)Yes10 81344 399711·60 (1·25--2·02)Unavailable[\*](#tbl1fn1){ref-type="table-fn"}121 584644 0233770·59 (0·53--0·65)Connective tissue--rheumatic diseaseNo526 4932 547 41530591·20 (1·16--1·24)Yes30 933140 8562231·58 (1·38--1·81)Unavailable[\*](#tbl1fn1){ref-type="table-fn"}121 584644 0233770·59 (0·53--0·65)CancerNo534 5342 590 79331701·22 (1·18--1·27)Non-metastatic cancer20 36487 849951·08 (0·87--1·32)Metastatic cancer25289629171·77 (1·03--2·83)Unavailable[\*](#tbl1fn1){ref-type="table-fn"}121 584644 0233770·59 (0·53--0·65)Cerebrovascular diseaseNo546 0472 640 62632211·22 (1·18--1·26)Yes11 37947 646611·28 (0·98--1·64)Unavailable[\*](#tbl1fn1){ref-type="table-fn"}121 584644 0233770·59 (0·53--0·65)Myocardial infarctionNo541 8492 619 16431861·22 (1·17--1·26)Yes15 57769 107961·39 (1·13--1·70)Unavailable[\*](#tbl1fn1){ref-type="table-fn"}121 584644 0233770·59 (0·53--0·65)Paraplegia and hemiplegiaNo555 2292 678 66932631·22 (1·18--1·26)Yes21979603191·98 (1·19--3·09)Unavailable[\*](#tbl1fn1){ref-type="table-fn"}121 584644 0233770·59 (0·53--0·65)Peptic ulcer diseaseNo549 0712 649 11632291·22 (1·18--1·26)Yes835539 155531·35 (1·01--1·77)Unavailable[\*](#tbl1fn1){ref-type="table-fn"}121 584644 0233770·59 (0·53--0·65)Peripheral vascular diseaseNo547 0962 645 53032071·21 (1·17--1·25)Yes10 33042 742751·75 (1·38--2·20)Unavailable[\*](#tbl1fn1){ref-type="table-fn"}121 584644 0233770·59 (0·53--0·65)Renal diseaseNo539 6052 628 85231971·22 (1·17--1·26)Yes17 82159 419851·43 (1·14--1·77)Unavailable[\*](#tbl1fn1){ref-type="table-fn"}121 584644 0233770·59 (0·53--0·65)**Surgical characteristics**OsteoarthritisNo18 52992 3711571·70 (1·44--1·99)Yes660 4813 239 92335021·08 (1·05--1·12)TraumaNo675 1933 313 91136131·09 (1·05--1·13)Yes381718 383462·50 (1·83--3·34)Previous knee infectionNo678 5223 329 98636441·09 (1·06--1·13)Yes4882309156·50 (3·64--10·72)Avascular necrosisNo676 5153 319 90036381·10 (1·06--1·13)Yes249512 394211·69 (1·05--2·59)Inflammatory arthropathyNo663 4103 251 20535341·09 (1·05--1·12)Yes15 60081 0891251·54 (1·28--1·84)Other indicationNo675 3123 317 11436361·10 (1·06--1·13)Yes369815 181231·52 (0·96--2·27)Surgical approachMedial parapatellar629 8913 093 8473 4201·11 (1·07--1·14)Midvastus19 38489 860760·85 (0·67--1·06)Lateral parapatellar799242 506471·11 (0·81--1·47)Subvastus940348 926491·00 (0·74--1·32)Other approach12 34057 155671·17 (0·91--1·49)ProcedurePrimary TKR cemented569 7372 760 94532271·17 (1·13--1·21)Primary TKR uncemented33 754188 6391530·81 (0·69--0·95)Primary TKR other769948 490521·07 (0·80--1·41)Unicondylar58 885291 9062110·72 (0·63--0·83)Patellofemoral893542 314160·38 (0·22--0·61)ConstraintUnconstrained fixed397 1751 918 70719871·04 (0·99--1·08)Unconstrained mobile47 532262 8752781·06 (0·94--1·19)Posterior stabilised fixed144 960705 7829811·39 (1·30--1·48)Posterior stabilised mobile971451 054541·06 (0·79--1·38)Constrained condylar296811 498433·74 (2·71--5·04)Fixed16 70374 967670·89 (0·69--1·14)Mobile41 297212 0861410·66 (0·56--0·78)Undetermined18 66195 3261081·13 (0·93--1·37)General anaesthesiaNo381 1561 788 49018891·06 (1·01--1·10)Yes297 8541 543 80417701·15 (1·09--1·20)Nerve block anaesthesiaNo547 7832 644 39329141·10 (1·06--1·14)Yes131 227687 9027451·08 (1·01--1·16)Epidural anaesthesiaNo621 5722 987 04333111·11 (1·07--1·15)Yes57 438345 2513481·01 (0·90--1·12)Spinal anaesthesiaNo283 1201 499 42217241·15 (1·10--1·21)Yes395 8901 832 87319351·06 (1·01--1·10)Thromboprophylaxis regimenChemical606 0012 870 43732041·12 (1·08--1·16)Non-chemical73 009461 8574550·99 (0·90--1·08)Femoral bone graftNo675 1473 317 92536351·10 (1·06--1·13)Yes386314 370241·67 (1·07--2·49)Tibial bone graftNo676 2713 319 18236291·09 (1·06--1·13)Yes273913 112302·29 (1·54--3·27)Intraoperative eventNo675 0893 314 5013636..Yes392117 794231·29 (0·82--1·94)**Health system characteristics**Country of surgeryEngland638 8353 136 01034611·10 (1·07--1·14)Wales40 175196 2851981·01 (0·87--1·16)FundingNHS574 4332 722 01330911·14 (1·10--1·18)Private75 507395 5143620·92 (0·82--1·01)Unspecified29 070214 7682060·96 (0·83--1·10)Grade of operating surgeonConsultant572 4642 767 93730321·10 (1·06--1·14)Other106 546564 3576271·11 (1·03--1·20)Consultant involvementOperating572 4642 767 93730321·10 (1·06--1·14)Assisting38 327188 7542231·18 (1·03--1·35)Not involved68 219375 6044041·08 (0·97--1·19)Total volume (operating surgeon) of knee replacements done in previous 12 months≤25173 288988 69410911·10 (1·04--1·17)\>25--50160 104815 8909831·20 (1·13--1·28)\>50--85170 157788 1398161·04 (0·97--1·11)\>85175 461739 5717691·04 (0·97--1·12)Total volume (surgeon in charge) of knee replacements done in previous 12 months≤38173 2041 010 73911131·10 (1·04--1·17)\>38--70174 209872 8169861·13 (1·06--1·20)\>70--110162 179730 8047911·08 (1·01--1·16)\>110169 418717 9367691·07 (1·00--1·15)Total volume (hospital) of knee replacements done in previous 12 months≤150167 9301 008 8529840·98 (0·92--1·04)\>150--285174 288863 1149731·13 (1·06--1·20)\>285--440169 780743 1028931·20 (1·12--1·28)\>440167 012717 2278091·13 (1·05--1·21)[^2][^3]

RRs of revision for prosthetic joint infection surgery are presented in [appendix pp 10--12](#sec1){ref-type="sec"}. [Figure 2](#fig2){ref-type="fig"} provides RRs over the entire follow-up and [figure 3](#fig3){ref-type="fig"} shows their effect within the first 3 postoperative months. Effects associated with other periods are presented in [appendix pp 15--18](#sec1){ref-type="sec"}.Figure 2Risk factors of revision for prosthetic joint infection during the overall postoperative period(A) Patient factors. (B) Surgery factors. (C) Health-care system factors. Reference categories are in parentheses. BMI=body mass index. ASA=American Society of Anesthesiologists. TKR=total knee replacement. NHS=National Health Service. \*Adjusted p value \<0·05, detailed in [appendix pp 10--12](#sec1){ref-type="sec"}, alongside the rate ratios and 95% CIs. †Volume refers to the total volume of knee replacements done within the previous 12 months.Figure 3Risk factors of revision for prosthetic joint infection in the first 3 postoperative months(A) Patient factors. (B) Surgery factors. (C) Health-care system factors. Reference categories are in parentheses. BMI=body mass index. ASA=American Society of Anesthesiologists. TKR=total knee replacement. NHS=National Health Service. \*Adjusted p value \<0·05, detailed in [appendix pp 10--12](#sec1){ref-type="sec"}, alongside the rate ratios and 95% CIs. †Volume refers to the total volume of knee replacements performed within the previous 12 months.

In terms of the role of patient characteristics, men were at a higher risk of revision for prosthetic joint infection in all time periods ([figure 2](#fig2){ref-type="fig"}). During the entire follow-up, the risk was lower for patients aged 60 years and older than in patients younger than 60 years of age. Patients aged 80 years and older were at increased risk of early revision for prosthetic joint infection but were at lower risk of revision thereafter ([appendix pp 10, 15--18](#sec1){ref-type="sec"}). Patients aged 60--79 years were at reduced risk of long-term revision for prosthetic joint infection ([appendix pp 10, 15--18](#sec1){ref-type="sec"}).

BMI of 30 kg/m^2^ or higher was associated with an increased risk of revision for prosthetic joint infection compared with BMI lower than 25 kg/m^2^ ([figure 2](#fig2){ref-type="fig"}), especially after the first year ([appendix pp 10, 15--18](#sec1){ref-type="sec"}). Compared with healthy patients, those with an ASA of 2 or higher were at increased risk ([figure 2](#fig2){ref-type="fig"}), especially beyond 6 months for ASA 3--5 and after 2 years for ASA 2 ([appendix pp 10, 16--18](#sec1){ref-type="sec"}).

Patients with a pre-existing history of chronic pulmonary disease, diabetes, liver disease, connective tissue or rheumatic disease, or peripheral vascular disease had a higher risk than those without pre-existing histories of these diseases ([figure 2](#fig2){ref-type="fig"}). Patients with a history of rheumatic disease had a higher risk of revision at most postoperative periods ([appendix p 10](#sec1){ref-type="sec"}). Those with liver disease were at higher risk of long-term revision than those without liver disease ([appendix pp 10, 15--18](#sec1){ref-type="sec"}). No or inconsistent time-specific effects were observed for the other comorbidities.

In terms of surgical characteristics, risk of revision for prosthetic joint infection varied according to the indication for the primary procedure. Patients operated on for osteoarthritis were less likely to be revised for prosthetic joint infection ([figure 2](#fig2){ref-type="fig"}). Those operated on for trauma, history of previous infection in the operated joint ([appendix p 11](#sec1){ref-type="sec"}), or an inflammation arthropathy were at increased risk of revision for prosthetic joint infection ([figure 2](#fig2){ref-type="fig"}), especially from 2 years post-operation ([figure 3](#fig3){ref-type="fig"}; [appendix pp 11, 15--17](#sec1){ref-type="sec"}). The indication for surgery did not affect the risk of early revision for prosthetic joint infection ([appendix p 11](#sec1){ref-type="sec"}). Patients operated on for trauma or with a history of previous infection were at an increased risk of revision from 1 year onwards ([appendix pp 11, 17--18](#sec1){ref-type="sec"}).

The risk of revision varied according to the type of procedure, implant fixation and constraint or bearing, with more extensive and complex procedures associated with an increased risk. Compared with cemented total knee replacement, patients who had an uncemented total knee replacement, a patellofemoral replacement, or an unicondylar replacement were at lower risk of revision for prosthetic joint infection ([figure 2](#fig2){ref-type="fig"}). From 6 months onwards, those with a unicondylar procedure were at lower risk of revision for prosthetic joint infection; the reduced risk of revision was observed from 1 year and 2 years onwards respectively for patellofemoral and uncemented total knee replacement procedures ([appendix pp 11, 16--18](#sec1){ref-type="sec"}).

The risk of revision was increased for patients with a posterior stabilised fixed-bearing implant or a constrained condylar implant compare with those with an unconstrained (or cruciate-retaining) fixed-bearing implant ([figure 2](#fig2){ref-type="fig"}): from 6 postoperative months onwards with a posterior stabilised fixed implant and beyond 1 year post-surgery for a constrained condylar implant ([appendix pp 11, 16--18](#sec1){ref-type="sec"}). The risk of revision was lower for patients with fixed or mobile bearing implants, and this finding was particularly evident from 6 months onwards for mobile bearing implants ([appendix pp 11, 16--18](#sec1){ref-type="sec"}).

The risk of revision for prosthetic joint infection was higher for patients who had received a general anaesthetic or tibial bone graft, and lower for those who had received a spinal anaesthetic. Little or no difference in the risk of revision for prosthetic joint infection was found for other anaesthetic techniques, thromboprophylaxis regimen, use of femoral bone graft, occurrence of intraoperative complication, or surgical approach.

In terms of health-care system characteristics, the risk of revision for prosthetic joint infection did not differ between Wales and England ([figure 2](#fig2){ref-type="fig"}). Privately funded procedures had a lower risk of revision than procedures funded by the NHS ([figure 2](#fig2){ref-type="fig"}), especially beyond 2 years ([appendix pp 11, 18](#sec1){ref-type="sec"}).

Revision for prosthetic joint infection was not affected by the grade of the operating surgeon, the presence or absence of a consultant surgeon during surgery, or by the volume of all knee procedures done by the operating surgeon or the surgeon in charge ([Figure 2](#fig2){ref-type="fig"}, [Figure 3](#fig3){ref-type="fig"}, [appendix pp 11, 15--18](#sec1){ref-type="sec"}).

The overall risk of revision for prosthetic joint infection was higher in high-volume hospitals than in low-volume hospitals ([figure 2](#fig2){ref-type="fig"}). Compared with hospitals with a small volume of activity, the risk of revision was higher in the first 3 months after primary surgery in hospitals that had done more than 440 knee procedures in the year preceding the index surgery ([figure 3](#fig3){ref-type="fig"}). No specific difference in the RRs were found beyond this period or for units doing lower volumes of knee procedures ([appendix pp 11, 15--18](#sec1){ref-type="sec"}).

Discussion {#cesec80}
==========

The revision burden for prosthetic joint infection after knee replacement is higher than that after hip replacement in England and Wales.[@bib10], [@bib18] In our cohort of 679 010 knee replacements, 3659 (0·53%) underwent revision for prosthetic joint infection compared with 2707 out of 623 253 (0·43%) hip replacements studied during the same period.[@bib13] However, revision within the first 3 months is proportionately less common (6·7% of knee replacements had revision surgery for infection *vs* 13·8% of hip replacements).

At the patient level, male patients, younger patients, and those with high BMI or more severe systemic disease, indicated by their ASA grade, had higher risk of revision for prosthetic join infection; however older patients (aged ≥80 years) were at high risk of early revision for prosthetic joint infection. This finding might reflect a tendency to treat older patients non-operatively with suppressive antibiotics in the longer term. Comorbidities that increased the risk of revision for prosthetic joint infection included chronic pulmonary disease, diabetes, liver disease, connective tissue or rheumatic diseases, and peripheral vascular disease. Treatment of these comorbidities and elevated BMI can potentially be optimised before surgery. A targeted preoperative intervention for male patients with high BMI and specific comorbidities could be a particularly relevant approach. Long-term vigilance seems to be important in those with liver disease. Our patient-level findings are concordant with the results of our study of infection after hip replacement,[@bib13] another large study of knee replacement,[@bib28] and systematic reviews.[@bib11], [@bib12] Thus, these results might be generalisable to a wide population of patients undergoing implant surgery of various types.

At the surgical level, some of our results are consistent with those in hip surgery, but others are not. In particular, different surgical approaches in knee replacement are not associated with revision for prosthetic joint infection, but the use of general anaesthetic is. In general, factors that are a surrogate marker for operative duration and complexity, such as general anaesthetic, the need for additional constraint, total rather than partial knee replacement, and the use of tibial bone grafts, are associated with increased risk of revision for prosthetic joint infection. Concordant with hip surgery and previous studies,[@bib11], [@bib12], [@bib28] patients undergoing joint replacement for trauma or inflammatory arthritis have an increased risk of revision for infection. This finding is unsurprising because inflammatory arthropathies such as rheumatoid arthritis and drugs used to treat these conditions, such as disease-modifying antirheumatic drugs are known to be immunosuppressive.[@bib29] The substantially higher risk of prosthetic joint infection in those with historical infection of the knee is a new finding, but again unsurprising, and might be due to quiescent bacteria or other immune conditions that predispose individuals to infection.

Factors at the health-care system level seem to be less important than patient or surgical characteristics, with no notable sustained associations across the time periods studied. As previously reported,[@bib28] higher volume centres seemed to have a higher overall risk of revision for prosthetic joint infection and in the early postoperative period, but this association was not seen in the time-specific analysis or when test multiplicity was accounted for, indicating that this effect is not significant and might reflect more rapid diagnosis and early management of prosthetic joint infection in these centres. Privately funded patients were associated with lower long-term risks than those whose treatment was funded by the NHS---a finding not mirrored in our hip study. This difference is likely to reflect residual confounding with variables not available in our analysis because of case selection. The funding source of the primary procedure might therefore be a proxy for socioeconomic status, a patient factor not directly measured in the National Joint Registry.

Smoking has previously been identified as a risk factor for prosthetic joint infection,[@bib11], [@bib30] and, although we did not have information about this, the surrogate comorbidity of chronic pulmonary disease was associated with increased risk. Evidence of an association between alcohol intake and increased risk has been inconsistent.[@bib31], [@bib32] We noted a higher risk in patients with liver disease, but this outcome might represent a number of pathologies, including alcohol-related liver disease, and non-alcoholic-related disease such as fatty liver disease, hepatitis, haemochromatosis, or primary biliary cirrhosis. Our study corroborates the previous findings of increased risk in patients with diabetes and rheumatoid arthritis.[@bib11]

The current study has several strengths. To our knowledge, this is the largest and most comprehensive evaluation of patient-related, surgical-related, and healthcare-related factors and their associations with the risk of revision for prosthetic joint infection of the knee. We used a large-scale cohort design comprising of a larger number of participants (\>600 000) than those of the most up-to-date reviews on the topic (n=375 895 and n=512 508 hip and knee replacements)[@bib11], [@bib12] or individual articles.[@bib33] Other strengths include the long-term follow-up of the cohort (median 4·6 years) and advanced statistical analyses, which include the evaluation of the effects of these potential risk factors in time-specific periods, which is appropriate because we have demonstrated that risk is not constant over time. There are also several limitations to our study. Although prospectively collected, our data are observational, and we can only draw inferences about the nature and magnitude of the associations, but not establish causation. In the UK, no agreed national gold standards are available to orthopaedic surgeons for the diagnosis of prosthetic joint infection. As such, the reported indication for revision of prosthetic joint infection in the National Joint Registry might vary between units. The approach used to diagnose prosthetic joint infection is, however, reflective of contemporary practice, with raised inflammatory markers, joint-specific symptoms, sinuses, and positive microbiological cultures.[@bib19] The diagnosis of prosthetic joint infection reflects a clinical judgement sufficient to lead the surgeon to conduct a very severe and invasive procedure tailored to tackle the infection. We also acknowledge issues relating to under-reporting of revision for prosthetic joint infection, and thus potentially lower incidence estimates.[@bib34] Linkage of the National Joint Registry data to microbiology data could reduce a posteriori any misdiagnoses of prosthetic joint infection, but has been shown to be of limited generalisability, with only 11·8% linkage achievable.[@bib35] The associations that we have identified might vary with different causative pathogens, but unfortunately we do not have the data to explore this concept. Our findings should be considered as conservative estimates of the risk factors with the strongest effects. The investigation into the effects of comorbidities was limited to a subset of National Joint Registry patients linked to Hospital Episode Statistics. This subset had higher ASA grade and therefore higher rate of revision for prosthetic joint infection than those excluded from these investigations, but they did not differ in terms of age, sex, BMI, or surgical characteristics, suggesting little evidence of differential selection bias. All other factors were investigated in the entire sample.

We have done appropriate modelling to adjust for known relevant confounders, but the possibility of residual confounding does exist. We had no specific data about confounders such as smoking and alcohol consumption, but have surrogate markers for these such as chronic pulmonary disease and liver disease. BMI data were not collected in the early years of the registry, necessitating imputation of the missing data, as with a previous study on this dataset.[@bib36] The duration of surgery is not collected in the National Joint Registry but the surgical characteristics influencing revision for prosthetic joint infection show that this factor is likely to have an important role: knee replacement type, fixation, and constraint are all associated with the duration, and complexity of surgery. This has previously been shown.[@bib28] Competing risk due to revision for another cause or death, which in combination affected 13% of the index primary knee replacements in the dataset during the period of observation ([figure 1](#fig1){ref-type="fig"}), could not be accounted for in the modelling strategy. This was a pragmatic decision because we chose a strategy focusing on time-specific effects while accounting for the clustering nature of the data, to disentangle the effects associated with surgical factors (likely to be more substantial in the short-term to mid-term follow-up) from those associated with health risk behaviours (likely to be more influential in the mid-term to long-term follow-up period). This strategy was optimal because there was evidence of non-proportional hazard rates ([figure 3](#fig3){ref-type="fig"}, [appendix pp 15--18](#sec1){ref-type="sec"}). Finally, it was not possible to investigate any ethnic disparities in terms of revision for prosthetic joint infection because of the small number of ethnic minority patients who underwent revision for prosthetic joint infection.

Knee replacement is an effective intervention to address the symptoms arising from degenerative knee conditions such as osteoarthritis. Although successful, complications can occur and prosthetic joint infection is a devastating example. Strategies should therefore be adopted to reduce the risk of infection. Modifiable risk factors could be ameliorated with targeted interventions that could lead to a reduction in the incidence of prosthetic joint infection. When risk factors are not modifiable, they should form part of the information used to counsel and prepare patients for surgery and can form the basis of targeted follow-up and monitoring strategies. The time period-specific effects of the identified risk factors should also form an integral part of the preparation for and management of knee replacement surgery. Overall, the results of this large cohort study could help to better inform the practice and delivery of knee replacement surgery.
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Data are accessible via application to the National Joint Registry Research Sub-Committee.
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[^1]: Joint first authors

[^2]: ASA=American Society of Anesthesiologists. TKR=total knee replacement. NHS=National Health Service.

[^3]: Information about ethnicity and comorbidities is only available for the 557 426 patients operated on in England with a Hospital Episodes Statistics record, no record in the Patient Episode Database for Wales, and no evidence of residency outside England. See [figure 1](#fig1){ref-type="fig"} and [appendix p 2](#sec1){ref-type="sec"} for more details.
